期刊文献+

青年男性心肌梗死的高密度脂蛋白胆固醇特点及其与冠状动脉病变的关系 被引量:2

原文传递
导出
摘要 该文探讨青年男性急性心肌梗死( acute myocar-dial infarction, AMI)患者高密度脂蛋白胆固醇(high density lipoprotein cholesterol,HDL—C)的特点及其与冠状动脉病变程度的关系。方法:回顾性分析2009—01-2011—12在首都医科大学附属北京安贞医院住院诊断为AMI并行冠状动脉造影手术的青年男性(年龄≤44岁)共278例,根据冠状动脉造影结果。
出处 《中华高血压杂志》 CAS CSCD 北大核心 2013年第10期1000-1000,共1页 Chinese Journal of Hypertension
  • 相关文献

同被引文献40

  • 1Mette Claassen,Kirsten C Sybrandy,Yolande E Appelman,Folkert W Asselbergs.Gender gap in acute coronary heart disease:Myth or reality?[J].World Journal of Cardiology,2012,4(2):36-47. 被引量:9
  • 2张成立,黄晓勇,吕树铮,杨秀华,杨凤军.青年与老年冠心病危险因素和冠状动脉造影比较分析[J].心肺血管病杂志,2005,24(2):101-102. 被引量:17
  • 3杨中锋,孙晓斐.高血压合并急性心肌梗死患者脉压的临床研究[J].内科,2007,2(1):12-14. 被引量:4
  • 4杨水祥,胡大一.以社区为中心加强我国中青年冠心病及猝死的防治[J].中国心血管病研究,2007,5(8):561-563. 被引量:28
  • 5Bagai A, White JA, Lokhnygina Y, et al. Routine early eptifibatide versus delayed provisional use at percutaneous coronary intervention in high - risk non - ST - segment elevation acute coronary syndromes patients: an analy- sis from the Early Glycoprotei Ilb/IIIa Inhibition in Non -ST- Segment Elevation Acute Coronary Syndrome trial [ J ]. Am Heart J, 2013,166 (3) : 466 - 473.
  • 6Montalescot G, Bolognese L, Dudek D, et at. Pretreatment with prasugrel in non - ST - segment elevation acute coronary syndromes [ J]. N Engl J Med, 2013,369(11): 999 - 1 010.
  • 7Acharjee S, Roe MT, Amsterdam EA, et al. Relation of admission high - density lipoprotein cholesterol level and in - hospital mortality in patients with acute non-ST segment elevation myocardial infarction (from the National Cardiovascular Data Registry) [ J ]. Am J Cardiol, 2013,112 (8) : 1 057 - 1 062.
  • 8Klutstein MW, Westerhout CM, Armstrong PW, et al. Radial versus femoral access,bleeding and ischemic events in patients with non -ST- segmentelevation acute coronary syndrome managed with an invasivestrategy[J]. Am Heart J,2013,165(4): 583 - 590.
  • 9Collet JP, Huber K, Cohen M, et al. A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial)[J]. Am J Cardiol,2013,112(9): 1 367 - 1 372.
  • 10Zahir H, Matsushima N, Halim AB, et al. Edoxaban administration follow- ing enoxaparin: a pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjects[J] .Thromb Haemost, 2012, 108(1): 166 - 175.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部